Axiogenesis AG
Records under this name other than patents Axiogenesis AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Axiogenesis AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,318,488 | Assay for drug discovery based on in vitro differentiated cells Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,321,997 | Tissue modeling in embryonic stem (ES) cell system Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,945,840 | Non-invasive, in vitro functional tissue assay systems Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,835,433 | Non-invasive, in vitro functional tissue assay systems Formerly held Term ended Term ended May 6, 2026 · USPTO record | Term ended | Term ended May 6, 2026 | USPTO record |
| US 9,726,662 | Assay for drug discovery based on in vitro differentiated cells Formerly held Term ended Ended no later than May 11, 2025 · USPTO record | Term ended | Ended no later than May 11, 2025 | USPTO record |
| US 8,148,152 | Method for the preparation of embryoid bodies (EBs) and uses thereof Formerly held Term ended Term ended Feb 9, 2025 · USPTO record | Term ended | Term ended Feb 9, 2025 | USPTO record |
| US 7,105,344 | Fluorescent proteins as cell-type specific reporters Term ended Term ended Apr 10, 2019 · USPTO record | Term ended | Term ended Apr 10, 2019 | USPTO record |